[HTML][HTML] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo, T Tamura… - Journal of …, 2015 - Elsevier
Background Activated partial thromboplastin time (aPTT) is recommended for monitoring
anticoagulant activity in dabigatran-treated patients; however, there are limited data in …

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non‐valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo… - Journal of …, 2015 - Wiley Online Library
Background Activated partial thromboplastin time (aPTT) is recommended for monitoring
anticoagulant activity in dabigatran‐treated patients; however, there are limited data in …

[PDF][PDF] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo… - Journal of …, 2015 - cyberleninka.org
abstract Background: Activated partial thromboplastin time (aPTT) is recommended for
monitoring anticoagulant activity in dabigatran-treated patients; however, there are limited …

[HTML][HTML] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo… - Journal of …, 2015 - ncbi.nlm.nih.gov
Background Activated partial thromboplastin time (aPTT) is recommended for monitoring
anticoagulant activity in dabigatran-treated patients; however, there are limited data in …

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non‐valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo… - Journal of …, 2015 - search.proquest.com
Background Activated partial thromboplastin time (aPTT) is recommended for monitoring
anticoagulant activity in dabigatran‐treated patients; however, there are limited data in …

[引用][C] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo, T Tamura… - Journal of …, 2015 - cir.nii.ac.jp
Relationship between plasma dabigatran concentration and activated partial thromboplastin
time in Japanese patients with non-valvular atrial fibrillation | CiNii Research CiNii 国立情報学 …

[PDF][PDF] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo, T Tamura… - Journal of …, 2015 - core.ac.uk
abstract Background: Activated partial thromboplastin time (aPTT) is recommended for
monitoring anticoagulant activity in dabigatran-treated patients; however, there are limited …

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation.

D Shimomura, Y Nakagawa, H Kondo… - Journal of …, 2014 - europepmc.org
BACKGROUND: Activated partial thromboplastin time (aPTT) is recommended for
monitoring anticoagulant activity in dabigatran-treated patients; however, there are limited …

[PDF][PDF] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo… - Journal of …, 2015 - researchgate.net
abstract Background: Activated partial thromboplastin time (aPTT) is recommended for
monitoring anticoagulant activity in dabigatran-treated patients; however, there are limited …

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

D Shimomura, Y Nakagawa, H Kondo… - Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Activated partial thromboplastin time (aPTT) is recommended for monitoring
anticoagulant activity in dabigatran-treated patients; however, there are limited data in …